Aug 13, 2024 / 07:30AM GMT
Michael Staheli - PolyPeptide Group AG - Head of Investor Relations and Corporate Communications
Good morning, everybody. Thank you for joining our call. I'm joined in the room by Juan José Gonzalez, our CEO; and Marc Augustin, our CFO. They will run you through the presentation, and then they are open to take your questions at the end.
As usual, I draw your attention to the disclaimer on slide number 2. Sandra already told you about the usual procedure regarding the Q&A. You can ask it over the phone or in the chat function.
And with that, over to you, Juan José.
Juan-Jose Gonzalez - PolyPeptide Group AG - Chief Executive Officer
Thank you, Michael, and good morning, everyone. Thank you for joining us today. The objective for this session is to give you an update in terms of our operation and organizational progress. Then, Marc will walk you through over our H1 financial results, including the upgrade for our 2024 guidance. And then, we'll step back and share with you how we see the peptide market evolving, what is our
Half Year 2024 PolyPeptide Group AG Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
